ORIC Pharmaceuticals, Inc.ORICNASDAQ
Loading
Operating Expenses Over TimeStrong
Percentile Rank88
3Y CAGR+15.6%
5Y CAGR+13.8%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+15.6%/yr
vs +42.3%/yr prior
5Y CAGR
+13.8%/yr
Consistent
Acceleration
-26.7pp
Decelerating
Percentile
P88
Within normal range
vs 5Y Ago
1.9x
Solid growth
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $141.78M | -0.0% |
| 2024 | $141.79M | +29.2% |
| 2023 | $109.75M | +19.6% |
| 2022 | $91.77M | +16.4% |
| 2021 | $78.87M | +6.3% |
| 2020 | $74.19M | +169.1% |
| 2019 | $27.57M | +23.2% |
| 2018 | $22.37M | +3.4% |
| 2017 | $21.64M | - |